文献速递重症综合管理与镇静镇痛心脑血管急症

组织运动瓣环位移在脓毒症心肌病中的可行性与鉴别价值:单中心回顾性观察研究

Feasibility and discriminatory value of tissue motion annular displacement in sepsis-induced cardiomyopathy: a single-center retrospective observational study.
PubMed 文献 · Crit Care · 2022-07-18
一句话结论基于斑点追踪的组织运动瓣环位移(TMAD)测量可行、耗时短,对预测LVEF<50%的脓毒症心肌病有良好鉴别价值,但TMAD不是28天及院内死亡的独立危险因素。

本研究为单中心回顾性观察研究,纳入143例入住后24小时内完成超声心动图检查的脓毒症或脓毒性休克患者。基于斑点追踪超声心动图离线测量整体纵向应变(GLS)与TMAD,比较TMAD、GLS、MAPSE及LVEF的参数获取率、观察者间与观察者内信度及测量耗时,并以AUROC评估各指标对LVEF<50%定义的脓毒症心肌病(SICM)的鉴别价值,同时分析TMAD对死亡的预后价值。结果显示TMAD参数获取率及信度最高、离线分析耗时显著短于LVEF或GLS,TMADMid预测SICM的AUROC>0.9;TMADMid<9.75 mm者28天及院内死亡率显著更高,但多因素Cox回归中BMI与SOFA是28天及院内死亡的独立危险因素,TMAD并非独立危险因素。

要点

  • 在143例脓毒症或脓毒性休克患者中,TMAD的参数获取率、观察者内与观察者间信度均高于LVEF、GLS或MAPSE。
  • TMAD离线分析平均耗时显著短于LVEF或GLS(p<0.05)。
  • TMADMid预测SICM(LVEF<50%)的AUROC>0.9,鉴别价值优秀。
  • TMADMid<9.75 mm者28天及院内死亡率均显著更高(均p<0.05)。
  • 多因素Cox回归显示BMI与SOFA是28天及院内死亡的独立危险因素,TMAD不是。

适用人群与场景

  • 脓毒症或脓毒性休克患者,且在入住后24小时内接受了超声心动图检查。

诊断标准与关键阈值

  • 脓毒症心肌病(SICM)定义为LVEF<50%。
  • TMADMid预测SICM的截断值为9.75 mm(低于此值者28天及院内死亡率显著更高)。

研究设计与关键结果

  • 研究类型:单中心回顾性观察研究,共纳入143例脓毒症或脓毒性休克患者。
  • 可行性:与LVEF、GLS或MAPSE相比,TMAD的参数获取率、观察者内与观察者间信度最高;TMAD离线分析平均耗时显著短于LVEF或GLS(p<0.05)。
  • 鉴别价值:AUROC分析显示TMADMid预测SICM(LVEF<50%)的AUROC>0.9。
  • 预后:TMADMid<9.75 mm者28天及院内死亡率均显著更高(均p<0.05)。
  • 多因素Cox比例风险模型:BMI和SOFA是脓毒症患者28天及院内死亡的独立危险因素,TMAD不是。

证据类型、等级与局限

  • 证据类型:单中心回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,基于斑点追踪超声心动图的TMAD是一项新颖且可行的技术,对预测LVEF<50%的SICM具有较好的鉴别价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is no formal diagnostic criterion for sepsis-induced cardiomyopathy (SICM), but left ventricular ejection fraction (LVEF) < 50% was the most commonly used standard. Tissue motion annular displacement (TMAD) is a novel speckle tracking indicator to quickly assess LV longitudinal systolic function. This study aimed to evaluate the feasibility and discriminatory value of TMAD for predicting SICM, as well as prognostic value of TMAD for mortality.

METHODS: We conducted a single-center retrospective observational study in patients with sepsis or septic shock who underwent echocardiography examination within the first 24 h after admission. Basic clinical information and conventional echocardiographic data, including mitral annular plane systolic excursion (MAPSE), were collected. Based on speckle tracking echocardiography (STE), global longitudinal strain (GLS) and TMAD were, respectively, performed offline. The parameters acquisition rate, inter- and intra-observer reliability, time consumed for measurement were assessed for the feasibility analysis. Areas under the receiver operating characteristic curves (AUROC) values were calculated to assess the discriminatory value of TMAD/GLS/MAPSE for predicting SICM, defined as LVEF < 50%. Kaplan-Meier survival curve analysis was performed according to the cutoff values in predicting SICM. Cox proportional hazards model was performed to determine the risk factors for 28d and in-hospital mortality.

RESULTS: A total of 143 patients were enrolled in this study. Compared with LVEF, GLS or MAPSE, TMAD exhibited the highest parameter acquisition rate, intra- and inter-observer reliability. The mean time for offline analyses with TMAD was significantly shorter than that with LVEF or GLS (p < 0.05). According to the AUROC analysis, TMADMid presented an excellent discriminatory value for predicting SICM (AUROC > 0.9). Patients with lower TMADMid (< 9.75 mm) had significantly higher 28d and in-hospital mortality (both p < 0.05). The multivariate Cox proportional hazards model revealed that BMI and SOFA were the independent risk factors for 28d and in-hospital mortality in sepsis cases, but TMAD was not.

CONCLUSION: STE-based TMAD is a novel and feasible technology with promising discriminatory value for predicting SICM with LVEF < 50%.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Song J, Yao Y, Lin S, et al. Feasibility and discriminatory value of tissue motion annular displacement in sepsis-induced cardiomyopathy: a single-center retrospective observational study. Crit Care. 2022. PMID: 35851427. doi:10.1186/s13054-022-04095-w

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。